摘要 |
The described invention provides methods for detecting, diagnosing and treating low- grade ovarian cancer and stage I ovarian cancer by comparing results from serum and ovarian tissue samples with normal controls. An increased level of expression of serine protease, wherein the serine protease is at least 2 selected from the group consisting of kallikrein 6 (KLK6), kallikrein 7 (KLK7), and PRSS8, expressed by subject samples compared to the level of expression of serine protease expressed by normal control samples is indicative of possible early stage ovarian cancer in the subject. Once early stage (I/II) ovarian cancer is diagnosed, the subject is treated with a treatment regimen effective to treat the early stage (I/II) ovarian cancer. |
申请人 |
SUH, K., STEPHEN;TAMIR, AYALA;PECORA, ANDREW, L. |
发明人 |
SUH, K., STEPHEN;TAMIR, AYALA;PECORA, ANDREW, L. |